Blueprint Medicines Corp (NQ: BPMC )
112.19
-1.50
(-1.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Blueprint Medicines Corp
![](https://cdn.benzinga.com/files/images/story/2023/08/21/bpmc.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Analyst Ratings for Blueprint Medicines
August 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
What 15 Analyst Ratings Have To Say About Blueprint Medicines
August 02, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/742419/nurse-tending-patient-in-intensive-care.jpg)
![](/next-assets/images/schema-image-default.png)
A Preview Of Blueprint Medicines's Earnings
August 01, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600d.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Analyst Ratings for Blueprint Medicines
July 14, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/737846/ma.jpg)
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Blueprint Medicines's Future
June 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/23/aapharma_12.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Blueprint Medicines
May 05, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Blueprint Medicines Stands With Analysts
April 19, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
16 Analysts Have This to Say About Blueprint Medicines
March 30, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/28/etf_movers.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/drug_stocks1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/05/epam_systems_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/29/bpmc.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/05/amedisys_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/05/saic_-_logo_copy_0.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Where Blueprint Medicines Stands With Analysts
February 27, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/05/meta_platforms_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/734030/two-scientists-sit-at-bench-using-microscopes.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/23/bpmc.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.